Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

    ... RATIONALE: Drugs used in chemotherapy , such as fludarabine and cyclophosphamide , ... able to replace blood-forming cells that were destroyed by chemotherapy and radiation therapy. Sometimes the transplanted cells from a ...

    Clinical Trial last updated 05/02/2016 - 2:13pm.

  2. Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System.

    ... care without specific therapy, with AML-like chemotherapy , or with other therapy regimens (low-dose chemotherapy, demethylating agents, immune modulating agents, valproic acid, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  4. Transplantation strategies for the management of patients with myelodysplastic syndromes.

    ... are almost equal with the results obtained by intensive chemotherapy alone. Failure was due primarily to TRM in patients with ... the procedure. Autologous SCT after successful induction chemotherapy may increase the proportion of long-term survivors, thus ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  6. A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    ...

    Clinical Trial last updated 04/27/2016 - 9:27am.

  7. How we treat higher-risk myelodysplastic syndromes

    ... hypomethylating agent therapy, induction chemotherapy or a clinical trial should be considered to prevent ...

    Research Article last updated 01/08/2014 - 8:57am.

  8. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management

    ... lenalidomide , hypomethylating agents, intensive chemotherapy , and allogeneic stem cell transplantation. The use of ...

    Research Article last updated 02/04/2014 - 1:37pm.

  9. The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

    ... yrs were more likely to receive active therapies (i.e., chemotherapy , immunomodulatory therapy, or epigenetic therapy) than ...

    Research Article last updated 10/22/2013 - 2:33pm.

  10. Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study

    ... received disease-modifying therapies (DMT) that included chemotherapy (CHT) for 65 patients, allogeneic stem-cell transplantation ...

    Research Article last updated 04/02/2013 - 7:59am.